A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma

201181 citationsReviewgold Open Access

Authors

Jing Hu · Renji Hospital

Gang Zhao · Renji Hospital

Hongxia Wang · Renji Hospital

Lei Tang · Renji Hospital

Yingchun Xu · Renji Hospital

Yue Ma · Renji Hospital

Fengchun Zhang · Suzhou Kowloon Hospital

Abstract

Gemcitabine in combination with capecitabine or oxaliplatin was associated with enhanced OS and ORR as compared with gemcitabine in monotherapy, which are likely to become the preferred standard first-line treatment of LA/MPC.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Neuroendocrine Tumor Research Advances Renal cell carcinoma treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Hematology & Oncology

Volume 4, Issue 1, pp. 11-11

DOI: 10.1186/1756-8722-4-11

Field-Weighted Citation Impact: 4.08